The Department of Pharmaceuticals has given ‘in-principle’ approval to the proposals of the three states —Himachal Pradesh, Gujarat and Andhra Pradesh—under the Scheme for ‘Promotion of Bulk Drug Parks’, an initiative to support drugs manufacturing in the country.
The scheme, notified in 2020 has a financial outlay of Rs 3,000 crores. It aims to provide financial assistance to three states for establishing Bulk Drug Parks and aims to bring down the cost of manufacturing bulk drugs by creating world-class common infrastructure facilities.
Course Purchase Query 